Research-Ready With >100 Clinical Sites
The PTN comprises over 100 clinical research sites, including leading pediatric hospitals and academic institutions. This assembly of experienced, research-ready sites allows for efficient study startup and conduct. Trial infrastructure remains in place from one study to the next, conserving resources.
Infrastructure That Makes Difficult Research Possible
Pediatric research presents special challenges, such as
- Need for specialized clinical and pharmacology expertise
- Difficulty testing very small amounts of blood
- Ethical concerns
The PTN provides scientific, technical, and administrative infrastructure to ensure that trials obtain valid results in a safe, ethical, and efficient manner:
Network Steering Committee
Danny Benjamin, MD, PhD, MPH, Duke University
Paula Delmore, Wesley Medical Center
Rachel G. Greenberg, MD, MB, MHS, Duke University
Chi Hornik, MD, PhD, Duke University | Learn more about Chi Hornik
Gregory Kearns, Pharm D, PhD, Children's Mercy Kansas City
Matthew Laughon, MD, University of North Carolina | Learn more about Matthew Laughon
Ian Paul, MD, Penn State
Susan Rahman, Pharm D, Children’s Mercy Research Institute | Learn more about Susan Rahman
Janice Sullivan, MD, University of Louisville
Kelly Wade, MD, PhD, MSCE, Children's Hospital of Philadelphia
Leanne West, PhD, Internal Children's Advisory Network (iCAN)
Kanecia Zimmerman, MD, MPH, Duke University
Other Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Best Pharmaceuticals for Children Act (BPCA) Program
- The Emmes Company, LLC (Coordinating Center)
- Thermo Fisher Scientific (Biological Specimens Repository)
Interested in joining PTN as a clinical research site?
Please complete our survey.
Contact the PTN Program Manager with any questions.